Carrick Therapeutics, transforming cancer treatments by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer
Location: United States, Massachusetts, Boston
Total raised: $137.97M
Investors 5
Date | Name | Website |
17.07.2021 | ARCH Ventu... | archventur... |
- | Spex Capit... | spexcapita... |
- | Lightstone... | lightstone... |
18.05.2023 | Cambridge ... | cic.vc |
- | GV | gv.com |
Funding Rounds 2
Date | Series | Amount | Investors |
01.12.2022 | Series C | $42.97M | - |
04.10.2016 | - | $95M | GV |
Mentions in press and media 19
Date | Title | Description | Source |
19.12.2022 | Carrick Therapeutics and the Menarini Group announce clinica... | Carrick Therapeutics and the Menarini Group announce clinical trial collaboration to evaluate samura... | cic.vc/new... |
19.12.2022 | Carrick Therapeutics and The Menarini Group Announce Clinica... | Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic b... | en.prnasia... |
02.12.2022 | Pfizer backs $60M infusion into Carrick, teams up on breast ... | Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment Endpoints article | by... | cic.vc/new... |
01.12.2022 | Carrick Therapeutics Announces $35 Million Investment from P... | - | globenewsw... |
17.08.2021 | Carrick Therapeutics to present first clinical data on Samur... | Carrick Therapeutics to present first clinical data on Samuraciclib (CT-7001), a first-in-class inhi... | cic.vc/new... |
16.08.2021 | Carrick receives FDA Fast Track designations for two samurac... | Carrick Therapeutics receives FDA Fast Track designations for two samuraciclib combinations for the ... | cic.vc/new... |
02.08.2021 | Carrick Therapeutics announces collaboration with Roche | Carrick Therapeutics announces collaboration with Roche to evaluate novel Samuraciclib combination t... | cic.vc/new... |
11.10.2018 | Carrick Therapeutics in-licenses targeted ovarian cancer tre... | - Exclusive worldwide licence deal adding to Carrick’s rapid pipeline expansion - Preparations for ... | cic.vc/new... |
30.11.2017 | First patient dosed in Carrick Therapeutics' phase 1 clinica... | Carrick Therapeutics announces that the first patient has been dosed in the phase 1 clinical program... | cic.vc/new... |
09.10.2017 | Carrick Capital launches third fund, targets $400m | San Francisco-based Carrick Capital has launched a $400m third fund two years after closing its seco... | altassets.... |
Show more